Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy

Clinical trial NCT05574504 · WITHDRAWN

Trial details

NCT number: NCT05574504
Sponsor: AdventHealth
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer Urothelial Carcinoma

Start date: 2023-05-08
Primary completion: 2026-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.